Literature DB >> 12833721

Other bacterial diseases as a potential consequence of bioterrorism: Q fever, brucellosis, glanders, and melioidosis.

Gene W Voskuhl1, Paul Cornea, Michael S Bronze, Ronald A Greenfield.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12833721

Source DB:  PubMed          Journal:  J Okla State Med Assoc        ISSN： 0030-1876


× No keyword cloud information.
  13 in total

1.  Burkholderia pseudomallei type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages.

Authors:  Mary N Burtnick; Paul J Brett; Vinod Nair; Jonathan M Warawa; Donald E Woods; Frank C Gherardini
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

2.  Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages.

Authors:  Mary N Burtnick; David DeShazer; Vinod Nair; Frank C Gherardini; Paul J Brett
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

3.  Burkholderia pseudomallei-induced expression of a negative regulator, sterile-alpha and Armadillo motif-containing protein, in mouse macrophages: a possible mechanism for suppression of the MyD88-independent pathway.

Authors:  M Pudla; K Limposuwan; P Utaisincharoen
Journal:  Infect Immun       Date:  2011-05-09       Impact factor: 3.441

Review 4.  Combating the great mimicker: latest progress in the development of Burkholderia pseudomallei vaccines.

Authors:  Nittaya Khakhum; Itziar Chapartegui-González; Alfredo G Torres
Journal:  Expert Rev Vaccines       Date:  2020-07-15       Impact factor: 5.217

5.  Revised structures for the predominant O-polysaccharides expressed by Burkholderia pseudomallei and Burkholderia mallei.

Authors:  Christian Heiss; Mary N Burtnick; Rosemary A Roberts; Ian Black; Parastoo Azadi; Paul J Brett
Journal:  Carbohydr Res       Date:  2013-08-24       Impact factor: 2.104

6.  Burkholderia thailandensis oacA mutants facilitate the expression of Burkholderia mallei-like O polysaccharides.

Authors:  Paul J Brett; Mary N Burtnick; Christian Heiss; Parastoo Azadi; David DeShazer; Donald E Woods; Frank C Gherardini
Journal:  Infect Immun       Date:  2010-11-29       Impact factor: 3.441

7.  The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei.

Authors:  Mary N Burtnick; Paul J Brett; Sarah V Harding; Sarah A Ngugi; Wilson J Ribot; Narisara Chantratita; Angelo Scorpio; Timothy S Milne; Rachel E Dean; David L Fritz; Sharon J Peacock; Joanne L Prior; Timothy P Atkins; David Deshazer
Journal:  Infect Immun       Date:  2011-02-07       Impact factor: 3.441

8.  Burkholderia mallei tssM encodes a putative deubiquitinase that is secreted and expressed inside infected RAW 264.7 murine macrophages.

Authors:  John Shanks; Mary N Burtnick; Paul J Brett; David M Waag; Kevin B Spurgers; Wilson J Ribot; Mark A Schell; Rekha G Panchal; Frank C Gherardini; Keith D Wilkinson; David Deshazer
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

9.  Comparison of the in vitro and in vivo susceptibilities of Burkholderia mallei to Ceftazidime and Levofloxacin.

Authors:  Barbara M Judy; Gregory C Whitlock; Alfredo G Torres; D Mark Estes
Journal:  BMC Microbiol       Date:  2009-05-09       Impact factor: 3.605

10.  Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders.

Authors:  Mary N Burtnick; Christian Heiss; Rosemary A Roberts; Herbert P Schweizer; Parastoo Azadi; Paul J Brett
Journal:  Front Cell Infect Microbiol       Date:  2012-08-15       Impact factor: 5.293
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.